Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
KABE Group B | KABEB | Sep 27, 2024 | 300.00 | -1.96 |
Kakel Max | KAKEL | Sep 27, 2024 | 11.00 | +4.76 |
Kallebäck Property Invest | KAPIAB | Sep 27, 2024 | 183.00 | 0.00 |
Kambi Group | KAMBI | Sep 27, 2024 | 134.00 | +2.13 |
Kancera | KAN | Sep 27, 2024 | 1.97 | -1.30 |
Karnell Group AB (publ) | KARNELB | Sep 27, 2024 | 45.98 | -0.80 |
Karnov Group | KAR | Sep 27, 2024 | 81.00 | -1.82 |
Karolinska Development B | KDEV | Sep 27, 2024 | 1.17 | -0.85 |
Katalysen Ventures AB | KAV | Sep 27, 2024 | 13.50 | 0.00 |
KebNi B | KEBNIB | Sep 27, 2024 | 1.22 | -0.33 |
Kentima Holding B | KENH | Sep 27, 2024 | 2.18 | -0.91 |
Kiliaro | KILI | Sep 27, 2024 | 0.24 | -0.41 |
Kinda Brave | BRAVE | Sep 27, 2024 | 1.65 | -2.65 |
Kindred Group SDB | KINDSDB | Sep 27, 2024 | 129.60 | +0.08 |
Kinnevik A | KINVA | Sep 27, 2024 | 83.62 | +2.92 |
Kinnevik B | KINVB | Sep 27, 2024 | 83.27 | +1.30 |
Kjell Group | KJELL | Sep 27, 2024 | 18.45 | -0.81 |
KlaraBo | KLARAB | Sep 27, 2024 | 20.15 | +0.75 |
Klaria Pharma Holding | KLAR | Sep 27, 2024 | 0.81 | +3.05 |
Klimator | KLIMAT | Sep 27, 2024 | 1.99 | -0.50 |
Knowit | KNOW | Sep 27, 2024 | 158.00 | +4.50 |
Kontigo Care | KONT | Sep 27, 2024 | 2.38 | -2.46 |
Kopparbergs B | KOBRB | Sep 27, 2024 | 119.50 | -1.24 |
Krona Public Real Estate | KRONA | Sep 27, 2024 | 43.20 | -0.46 |
Kvix | KVIX | Sep 27, 2024 | 0.44 | +0.46 |
Lagercrantz Group B | LAGRB | Sep 27, 2024 | 191.90 | +0.26 |
Lammhults Design Group B | LAMMB | Sep 27, 2024 | 23.00 | +2.22 |
Latour B | LATOB | Sep 27, 2024 | 314.30 | -2.57 |
LC-Tec Holding | LCT | Sep 27, 2024 | 0.36 | 0.00 |
Leading Edge Materials Corp. | LEMSE | Sep 27, 2024 | 0.84 | +1.45 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.